Congress must also act to improve access to more affordable prescription medications
“I applaud the FDA Commissioner for his continued efforts to improve competition in the pharmaceutical industry and timely access to safe lower-cost generic prescription drugs. The new FDA guidance announced today calling for voluntary action by drug makers is an important step in the right direction, but this cannot be the end of our efforts to stop bad behavior by some drug companies. The bipartisan CREATES Act, which I’ve cosponsored, would require that brand name drug makers cooperate with generic manufacturers so that more affordable generic alternatives can be brought to the marketplace in a timely fashion. Congress should take up and pass this commonsense consumer-minded bill without further delay,” Grassley said.